Finzati - Logo
AMPH logo

Amphastar Pharmaceuticals, Inc.

AMPH • Drug Manufacturers - Specialty & Generic
$25.43
▼ -0.51 (-1.97%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Solid company profile with reasonable valuation support. The data suggests a balanced quality/value setup.
Market Cap
$873.48M
Growth
0.3%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 13.6%Positive revenue growth · 13.9%Positive free cash flow · 2.59Consistent free cash flow · 5/5Reasonable earnings multiple · 12.76
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:16 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$25.43
Change-1.97%
Market Cap$873.48M
52W Range16.65 - 31.26
Beta0.89
Gross Margin49.46%
Oper. Margin19.50%
Profit Margin13.63%
Debt/Eq0.83
Current Ratio4.02
Quick Ratio2.90
Revenue 5Y0.29%

Investment DNA

How strong this company looks for long-term investors

83
out of 100
Business Quality
Margins, moat, returns
68/100
Financial Strength
Debt, cash, stability
82/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
86/100
Why this score▼
Stable or improving margins · 13.6%Positive revenue growth · 13.9%Positive free cash flow · 2.59Consistent free cash flow · 5/5Reasonable earnings multiple · 12.76Manageable debt level · 0.83

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$19.00
Mean
$20.50
Median
$20.50
High
$22.00

Company Overview

IPO: 6/25/2014
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 1.59
Debt / Equity i: 0.83
Operating Margin: 19.50%
Net Margin: 13.63%
ROE i: -
ROIC: -

Financial Health

Score16 / 20
Debt / Equity: 0.83
Current Ratio: 4.02
Quick Ratio: 2.90
Status: Strong

Insider Transactions

Recent executive and insider activity

Pierce Anthony T
Transaction: 07/09/2026
OTHER
Change
0
Price
Not reported
Filing
07/13/2026
Type
OTHER
Pierce Anthony T
Transaction: 07/09/2026
BUY
Change
+7,886
Price
Not reported
Filing
07/13/2026
Type
BUY
Pierce Anthony T
Transaction: 07/09/2026
BUY
Change
+16,646
Price
$19.02
Filing
07/13/2026
Type
BUY